Urgent Care for aphthous ulcers, cold sores and dry sockets
Orafate (polymerized and cross-linked sucralfate) is associated with rapid healing and treatment of canker sores (aphthous ulcers), cold sores (herpes labialis) and dry sockets (alveolar osteitis)
Orafate is a new post-surgical treatment for oral wounds
Orafate is FDA-cleared and addresses the unmet dental needs caused by mild to moderate gingivitis, dental procedure wounds, post-op surgical wounds and severe periodontitis
Orafate™ accelerates the healing while reducing the pain
Orafate™ can be used by ENT surgeons to effectively accelerate the healing of post-op surgical wounds of tonsillectomies and uvuloplasty
Urgent Care for aphthous ulcers, cold sores and dry sockets
Orafate (polymerized and cross-linked sucralfate) is associated with rapid healing and treatment of canker sores (aphthous ulcers), cold sores (herpes labialis) and dry sockets (alveolar osteitis)
In-Office Orafate Procedures andOut-of-Office Prescription
Orafate™, a new FDA prescription
oral wound medical device,
containing enhanced potency
sucralfate, is being launched for
use as a reimbursable in-office
procedure, following all
cleanings and all extractions,
reimbursable under ADA procedure
code D9630. [Learn More]
Orafate™ is a patented high potency
reformulation of sucralfate used for
the management of oral wounds and
inflammation. The clinical effects of
Orafate is conveyed solely
through its physical contact with the
inflamed, injured or ulcerated lining.
Orafate™ should be used 3 times daily
for the 1st day then twice daily for
1 week or as directed by the dentist
or healthcare provider. [Read more]